Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

Adrenocortical neoplasms: role of prognostic markers MIB-1, P53, and RB.

Vargas MP, Vargas HI, Kleiner DE, Merino MJ.

Am J Surg Pathol. 1997 May;21(5):556-62.

PMID:
9158680
2.

The role of prognostic markers (MiB-1, RB, and bcl-2) in the diagnosis of parathyroid tumors.

Vargas MP, Vargas HI, Kleiner DE, Merino MJ.

Mod Pathol. 1997 Jan;10(1):12-7.

PMID:
9021722
3.

Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms.

Goldblum JR, Shannon R, Kaldjian EP, Thiny M, Davenport R, Thompson N, Lloyd RV.

Mod Pathol. 1993 Nov;6(6):663-8.

PMID:
7508113
4.

p53 and Ki67 in adrenocortical tumors.

Arola J, Salmenkivi K, Liu J, Kahri AI, Heikkilä P.

Endocr Res. 2000 Nov;26(4):861-5.

PMID:
11196463
5.

Clinical features and immunoexpression of p53, MIB-1 and proliferating cell nuclear antigen in adrenal neoplasms.

Martins AC, Cologna AJ, Tucci S Jr, Suaid HJ, Falconi RA.

J Urol. 2005 Jun;173(6):2138-42.

PMID:
15879867
6.

Expression of cell cycle inhibitor p27 and Ki-67 in human adrenocortical neoplasms.

Nakazumi H, Sasano H, Iino K, Ohashi Y, Orikasa S.

Mod Pathol. 1998 Dec;11(12):1165-70.

PMID:
9872646
8.

p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions.

Thapar K, Scheithauer BW, Kovacs K, Pernicone PJ, Laws ER Jr.

Neurosurgery. 1996 Apr;38(4):765-70; discussion 770-1.

PMID:
8692397
9.

Apoptosis control and proliferation marker in human normal and neoplastic adrenocortical tissues.

Bernini GP, Moretti A, Viacava P, Bonadio AG, Iacconi P, Miccoli P, Salvetti A.

Br J Cancer. 2002 May 20;86(10):1561-5.

11.
12.

Pathobiology of pituitary adenomas and carcinomas.

Scheithauer BW, Gaffey TA, Lloyd RV, Sebo TJ, Kovacs KT, Horvath E, Yapicier O, Young WF Jr, Meyer FB, Kuroki T, Riehle DL, Laws ER Jr.

Neurosurgery. 2006 Aug;59(2):341-53; discussion 341-53.

PMID:
16883174
14.

IGFII and MIB1 immunohistochemistry is helpful for the differentiation of benign from malignant adrenocortical tumours.

Schmitt A, Saremaslani P, Schmid S, Rousson V, Montani M, Schmid DM, Heitz PU, Komminoth P, Perren A.

Histopathology. 2006 Sep;49(3):298-307.

PMID:
16918977
16.

Usefulness of endoscopic biopsy using immunostaining of p53 and Ki-67 in tumors of the ampulla of Vater.

Kubota K, Kakuta Y, Kawamura S, Saito S, Seki H, Kuniyoshi T.

Pathol Int. 2003 Jun;53(6):361-70.

PMID:
12787310
17.

p53 and Ki-67 immunoreactivity and nuclear morphometry of 'carcinoma-in-adenoma' and adenoma of the gall-bladder.

Takei K, Watanabe H, Itoi T, Saito T.

Pathol Int. 1996 Nov;46(11):908-17.

PMID:
8970203
18.

p53 and Ki-67 immunoreactivity and nuclear morphometry of 'carcinoma-in-adenoma' and adenoma of the gall-bladder.

Takei K, Watanabe H, Itoi T, Saito T.

Pathol Int. 1996 Jun;46(6):426-35. Corrected and republished in: Pathol Int. 1996 Nov;46(11):908-17.

PMID:
8869994
19.
20.

Expression of retinoblastoma gene product and p21 (WAF1/Cip 1) protein in gliomas: correlations with proliferation markers, p53 expression and survival.

Korkolopoulou P, Kouzelis K, Christodoulou P, Papanikolaou A, Thomas-Tsagli E.

Acta Neuropathol. 1998 Jun;95(6):617-24.

PMID:
9650754

Supplemental Content

Support Center